NKI-AVL

Futó vizsgálatok

• Toboroz

  Prospective Data Collection Initiative on Thoracic Malignancies

  NCT06996249· Forrás

• Toboroz

  The PROOV Study: Exploiting the Synergistic Effect of PARP Inhibition With Cisplatin and Hyperthermia During Interval Cytoreductive Surgery and HIPEC in Ovarian Cancer

  NCT07460180· 1/2. fázis· Forrás

• Toboroz

  The Radium-select Study

  NCT06659926· Forrás

• Toboroz

  Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer

  NCT05522660· 3. fázis· Forrás

• Toboroz

  The Prognostic Role of Lymph Node Dissection In Men With Prostate Cancer Treated With Radical Prostatectomy

  NCT05109910· Forrás

• Toboroz

  Circulating Tumor DNA Based Adjuvant Chemotherapy in Stage II Colon Cancer Patients: the MEDOCC-CrEATE Trial

  NCT06434896· Forrás

• Fut, nem toboroz

  Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer

  NCT03425838· 3. fázis· Forrás

• Fut, nem toboroz

  A Study in Participants Previously Enrolled in a Genentech- and/or F. Hoffmann-La Roche Ltd-Sponsored Atezolizumab Study (IMbrella A)

  NCT03148418· 3. fázis· Forrás

• Fut, nem toboroz

  Rectal Cancer And Pre-operative Induction Therapy Followed by Dedicated Operation. The RAPIDO Trial

  NCT01558921· 3. fázis· Forrás

• Fut, nem toboroz

  Neo Adjuvant Chemotherapy in Triple Negative Breast Cancer

  NCT01057069· 2/3. fázis· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Prosztatarák2 toboroz
• Tüdőrák2 toboroz
• Melanóma1 toboroz
• Mezotelióma1 toboroz
• Petefészekrák1 toboroz
• Vastagbélrák1 toboroz

Kutatók

Ide még nem kötődik kutató.

Lezárt vizsgálatok

• Lezárult

  A Study to Evaluate the Safety and Efficacy of CyPep-1 in Combination With Pembrolizumab for the Treatment of Advanced or Metastatic Cancers

  NCT05383170· 1/2. fázis· Forrás

• Lezárult

  Study To Evaluate Safety, Pharmacokinetics, Pharmacodynamics, And Preliminary Anti-Tumor Activity Of RO7122290 In Combination With Cibisatamab With Obinutuzumab Pre-Treatment

  NCT04826003· 1. fázis· Forrás

• Lezárult

  Melanoma Patients Immunized with Natural DenDritic Cells

  NCT02993315· 3. fázis· Forrás